Skip to main content
Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Abrocitinib more promising than dupilumab in moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
0.67
Concept
Lead
score
Atopic Dermatitis
0
0.78
Pruritus
0
0.58
Topical Therapy
0
0.58
Eczema
0
0.29
Severity Index
0
0.29
Edit Tags